VIROPHARMA (NASDAQ:VPHM)
7.78
+0.01 (0.13%)
| VIROPHARMA (NASDAQ:VPHM) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $7.77 | 52 Week High | $14.55 | ||
| Open | $7.80 | 52 Week Low | $3.79 | ||
| Day High | $7.93 | P/E | N/A | ||
| Day Low | $7.69 | EPS | $-0.34 | ||
| Volume | 439,316 | ||||
| More VPHM Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| WXS | 3 | RSYS | 2 |
| SPN | 2 | GD | 2 |
| GT | 2 | UIS | 2 |
| BDN | 2 | HBAN | 1 |
| CSCO | 1 | WSII | 1 |
| BOKF | 1 | DINE | 1 |
Entities who have mentioned VPHM
- Merriman Curhan Ford | View Related Stories »
- Lazard | View Related Stories »
- Thomas Weisel Partners Group | View Related Stories »
- ThinkEquity | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
- Notable Calls | View Related Stories »
- Citi | View Related Stories »
- 13G | View Related Stories »
- Scopia Capital | View Related Stories »
- Bankruptcy | View Related Stories »
- Dividend | View Related Stories »
- Unusual 11 Mid-Day Movers | View Related Stories »
- Susquehanna International Group of Companies | View Related Stories »
- Treasury Capital Purchase Program | View Related Stories »
- Crude Oil | View Related Stories »
- UBS | View Related Stories »
- Trading Radar | View Related Stories »
- Life, Style and Real Estate | View Related Stories »
- Cantor Fitzgerald | View Related Stories »
- Credit Suisse | View Related Stories »
- Robert W Baird | View Related Stories »
- Collins Stewart | View Related Stories »
- Barclays | View Related Stories »
- Notable Analyst Rating Changes | View Related Stories »
- Fidelity Investments | View Related Stories »
View All Major News StreetInsider.com Major News for VPHM
- ViroPharma (VPHM) Posts Q3 EPS of $0.26, In-Line with Estimates
- ViroPharma (VPHM) Tops Q2 Bottom and Top Line Views
- ViroPharma (VPHM) Reports Q1 Loss
View All ReportsStreetInsider.com Reports on VPHM
- ThinkEquity Upgrades ViroPharma (VPHM) to Buy
- Trading Radar for 10/28: First Solar (FSLR), ConocoPhillips (COP), WellPoint (WLP), Goodyear (GT), Int. Paper (IP) Report
- Morning Movers 10/28: CSBC, QTM, ANIK, RSYS, PEET, WSII Higher; CALC, KSP, PSYS, VCLK, VPHM, GT Lower
- ViroPharma (VPHM) Posts Q3 EPS of $0.26, In-Line with Estimates
- Notable Analyst Rating Changes 9/28: CSCO, VPHM, ACN, AMAT, GD Upgraded; RBS, WFR, ISRG, WXS Downgraded
View All Press ReleasesCompany Press Releases on VPHM
- Personalized Pharmaceutical Systems Announces Sale of Angioedema Clinical Prediction Guide to Viropharma Incorporated
- ViroPharma to Present at Three November Healthcare Conferences
- ViroPharma Incorporated Reports Third Quarter 2009 Financial Results
- ViroPharma to Release 2009 Third Quarter Financial Results on October 28, 2009
StreetInsider Reports on VPHM by Category
View All BlogsBlogs on VPHM
- Biotech Stocks for a Possible Year-End Rally
- ViroPharma Incorporated Q3 2009 Earnings Call Transcript
- Biotech: Q3 Market Update
- Genzyme: Near Term Sell, Long Term Buy
- ViroPharma Finally Able to Look Forward
View All FilingsSEC Filings on VPHM
- Form 10-Q VIROPHARMA INC For: Sep 30
- Form 8-K VIROPHARMA INC For: Oct 28
- Form 8-K VIROPHARMA INC For: Oct 20
- Form SC 13G VIROPHARMA INC Filed by: FMR LLC
Comments on VPHM
No comments are currently available.
